A Switch in Metabolism Precedes Increased Mitochondrial Biogenesis in Respiratory Chain-Deficient Mouse Hearts

Total Page:16

File Type:pdf, Size:1020Kb

A Switch in Metabolism Precedes Increased Mitochondrial Biogenesis in Respiratory Chain-Deficient Mouse Hearts A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts Anna Hansson*, Nicole Hance*, Eric Dufour*, Anja Rantanen*, Kjell Hultenby†, David A. Clayton‡, Rolf Wibom§, and Nils-Go¨ ran Larsson*¶ Departments of *Medical Nutrition and Biosciences and §Laboratory Medicine and †Clinical Research Center, Karolinska Institutet, Novum, Karolinska University Hospital, S-141 86 Stockholm, Sweden; and ‡Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 Communicated by Rolf Luft, Karolinska Institutet, Stockholm, Sweden, December 30, 2003 (received for review November 15, 2003) We performed global gene expression analyses in mouse hearts plified by increased levels of transcripts encoding the glycolytic with progressive respiratory chain deficiency and found a meta- enzyme GAPDH in respiratory chain-deficient heart muscle bolic switch at an early disease stage. The tissue-specific mitochon- (14) and normal GAPDH transcript levels in respiratory chain- drial transcription factor A (Tfam) knockout mice of this study deficient cerebral cortex (9). Our studies have also demonstrated displayed a progressive heart phenotype with depletion of mtDNA that the mitochondrial mass increases in respiratory chain- and an accompanying severe decline of respiratory chain enzyme deficient embryos and differentiated mouse tissues, suggesting activities along with a decreased mitochondrial ATP production that increased mitochondrial biogenesis represents a cellular rate. These characteristics were observed after 2 weeks of age and compensatory mechanism. Measurement of the MAPR has became gradually more severe until the terminal stage occurred at demonstrated that an increase of mitochondrial mass increases 10–12 weeks of age. Global gene expression analyses with mi- overall ATP production to near normal levels in mitochondrial croarrays showed that a metabolic switch occurred early in the myopathy mice (11). MAPR may thus not be as critical for the progression of cardiac mitochondrial dysfunction. A large number pathophysiology of respiratory chain deficiency as previously of genes encoding critical enzymes in fatty acid oxidation showed thought, and other mechanisms, such as changes in reduction͞ decreased expression whereas several genes encoding glycolytic oxidation status and secondary metabolic alterations, may be enzymes showed increased expression. These alterations are con- important. In this article, we have characterized temporal sistent with activation of a fetal gene expression program, a changes in gene expression patterns and induction of mitochon- well-documented phenomenon in cardiac disease. An increase in drial biogenesis in Tfam knockout mouse hearts with progressive mitochondrial mass was not observed until the disease had respiratory chain deficiency. Surprisingly, we found that an early reached an advanced stage. In contrast to what we have earlier switch in metabolism may worsen the situation and contribute to observed in respiratory chain-deficient skeletal muscle, the in- the disease progression in respiratory chain-deficient hearts. creased mitochondrial biogenesis in respiratory chain-deficient heart muscle did not increase the overall mitochondrial ATP pro- Materials and Methods duction rate. The observed switch in metabolism is unlikely to Mating and Genotyping of Transgenic Animals. TfamloxP͞TfamloxP benefit energy homeostasis in the respiratory chain-deficient mice of mixed genetic background (10, 12) were mated to hearts and therefore likely aggravates the disease. It can thus be heterozygous transgenic mice (ϩ͞Ckmm-NLS-cre) (15). Double concluded that at least some of the secondary gene expression heterozygotes (ϩ͞TfamloxP,ϩ͞Ckmm-NLS-cre) were obtained alterations in mitochondrial cardiomyopathy do not compensate and backcrossed to the TfamloxP͞TfamloxP strain to generate but rather directly contribute to heart failure progression. tissue-specific knockouts (TfamloxP͞TfamloxP,ϩ͞Ckmm-NLS- cre). We analyzed a total of 416 offspring from this cross and espiratory chain dysfunction can generate symptoms in observed Mendelian distribution of the four obtained genotypes: loxP͞ loxP ϩ͞ ϭ loxP͞ almost any organ with varying ages of onset (1, 2). Many Tfam Tfam , Ckmm-NLS-cre (n 93), Tfam R TfamloxP (n ϭ 105), ϩ͞TfamloxP (n ϭ 116), and ϩ͞TfamloxP,ϩ͞ distinct genetic mitochondrial disease syndromes caused by ϭ mutations in nuclear genes or mtDNA have been extensively Ckmm-NLS-cre (n 102). studied (3). Furthermore, mitochondrial dysfunction is also RNA Isolation, Target Preparation, and Microarray Hybridization. implicated in common age-associated diseases as well as in the ͞ normally occurring aging process (4, 5). Respiratory chain Total RNA was isolated by using the TRIzol Reagent (GIBCO dysfunction thus plays an important role in human pathology, BRL) and equal amounts of RNA from at least four animals and it has generally been assumed that the pathogenesis is were pooled for each experiment. Target preparation and hy- directly related to deficient mitochondrial ATP production rate bridization to Affymetrix Mu11K Probe Arrays were performed (MAPR). However, there is very little direct experimental according to the protocol supplied by Affymetrix (Santa support for this hypothesis, and other mechanisms may have Clara, CA). been overlooked. Gene expression studies of respiratory chain- deficient budding yeast cells have demonstrated a variety of Microarray Data Analysis. Raw data were analyzed with the Af- responses, including major reconfiguration of the metabolic fymetrix software MICROARRAY SUITE 4.0. We used global scaling pathways and induction of peroxisomal biogenesis (6). We have to correct for differences in hybridization performance between generated mouse models for studies of the pathogenesis of the arrays. Only values scored as ‘‘Present’’ by the software were respiratory chain deficiency in vivo by using a conditional knockout strategy to disrupt the mitochondrial transcription Abbreviations: Tfam, mitochondrial transcription factor A; MAPR, mitochondrial ATP factor A (Tfam) gene in selected cell types (7–12). Increased cell production rate; PPAR␣, peroxisome proliferator activated receptor ␣; CS, citrate synthase; death is a common consequence of prolonged respiratory chain PFK, phosphofructokinase; LS, late-stage; MS, mid-stage; Hk1, hexokinase I; PGK, phos- deficiency, with the mechanism for cell death induction differing phoglycerate kinase. between affected tissues (8, 9, 13, 14). We have found evidence ¶To whom correspondence should be addressed. E-mail: [email protected]. for tissue-specific secondary alterations of metabolism as exem- © 2004 by The National Academy of Sciences of the USA 3136–3141 ͉ PNAS ͉ March 2, 2004 ͉ vol. 101 ͉ no. 9 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0308710100 Downloaded by guest on September 29, 2021 used for analysis. Genes with no ‘‘Present’’ values for any of the effects on the other enzyme activities. The homogenate was experiments were eliminated, resulting in a data set of 7,706 stored at Ϫ80°C for subsequent analyses of the following enzyme genes. The intensities for each probe set, designated average activities: hexokinase (HXK, EC 2.7.1.1) (22), glucose-6- differences (AvgDiff) by the software, were averaged for all phosphate isomerase (GPI, EC 5.3.1.9) (23), PFK (EC 2.7.1.11) experiments and used as the denominator to calculate a fold (24), and phosphoglycerate kinase (PGK, EC 2.7.2.3) (25). change ratio for each gene and experiment. The ratios were log All enzyme activities were determined spectrophotometrically transformed, and the data were analyzed by the CLUSTER at 35°C. program (16). We filtered the data to keep genes with data available for at least 90% of the samples. We then performed Statistical Analyses. A two-way ANOVA was used to analyze the hierarchical clustering of the arrays, by using average linkage statistical significance of observed difference in enzyme activi- clustering. The results were displayed with the TREEVIEW pro- ties and MAPR. gram (16). Each branch of the resulting array tree contained a number of experiments that were used as a group for further Results analyses. The mean intensity (mean AvgDiff) for each gene and Progressive Cardiomyopathy and Increased Mitochondrial Mass in group was calculated and compared with the other groups to Knockout Mice. We have previously characterized a mouse strain obtain the fold change of their respective intensities. The Student with tissue-specific disruption of Tfam in the heart and skeletal t test was used to compare the different groups. The signal muscle (TfamloxP͞TfamloxP,ϩ͞Ckmm-cre) causing dilated cardio- intensities for a gene represented by two or more probe sets were myopathy, atrioventricular heart conduction blocks, and death at normalized to each other and then used to calculate the fold 2–4 weeks of age (10). This strain does not develop a muscle change and the P value. Annotations and gene ontology infor- phenotype during their limited life span (10), consistent with our mation were obtained from the NetAffx Analysis Center, avail- recent observation that it takes Ϸ4 months before TFAM able on the Affymetrix website (17). We further categorized the protein depletion in skeletal muscle causes severely reduced genes manually according to function as defined by public MAPR (11). The usefulness of this knockout strain was limited databases and literature. because of short postnatal survival, and the
Recommended publications
  • Progressive Increase in Mtdna 3243A>G Heteroplasmy Causes Abrupt
    Progressive increase in mtDNA 3243A>G PNAS PLUS heteroplasmy causes abrupt transcriptional reprogramming Martin Picarda, Jiangwen Zhangb, Saege Hancockc, Olga Derbenevaa, Ryan Golhard, Pawel Golike, Sean O’Hearnf, Shawn Levyg, Prasanth Potluria, Maria Lvovaa, Antonio Davilaa, Chun Shi Lina, Juan Carlos Perinh, Eric F. Rappaporth, Hakon Hakonarsonc, Ian A. Trouncei, Vincent Procaccioj, and Douglas C. Wallacea,1 aCenter for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; bSchool of Biological Sciences, The University of Hong Kong, Hong Kong, People’s Republic of China; cTrovagene, San Diego, CA 92130; dCenter for Applied Genomics, Division of Genetics, Department of Pediatrics, and hNucleic Acid/Protein Research Core Facility, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; eInstitute of Genetics and Biotechnology, Warsaw University, 00-927, Warsaw, Poland; fMorton Mower Central Research Laboratory, Sinai Hospital of Baltimore, Baltimore, MD 21215; gGenomics Sevices Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806; iCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; and jDepartment of Biochemistry and Genetics, National Center for Neurodegenerative and Mitochondrial Diseases, Centre Hospitalier Universitaire d’Angers, 49933 Angers, France Contributed by Douglas C. Wallace, August 1, 2014 (sent for review May
    [Show full text]
  • 82870547.Pdf
    ORIGINAL RESEARCH published: 06 March 2017 doi: 10.3389/fpls.2017.00291 Integrated Transcriptome and Metabolic Analyses Reveals Novel Insights into Free Amino Acid Metabolism in Huangjinya Tea Cultivar Qunfeng Zhang 1, 2, Meiya Liu 1, 2 and Jianyun Ruan 1, 2* 1 Tea Research Institute, Chinese Academy of Agricultural Sciences, Hangzhou, China, 2 Key Laboratory for Plant Biology and Resource Application of Tea, The Ministry of Agriculture, Hangzhou, China The chlorotic tea variety Huangjinya, a natural mutant, contains enhanced levels of free amino acids in its leaves, which improves the drinking quality of its brewed tea. Consequently, this chlorotic mutant has a higher economic value than the non-chlorotic Edited by: varieties. However, the molecular mechanisms behind the increased levels of free amino Basil J. Nikolau, Iowa State University, USA acids in this mutant are mostly unknown, as are the possible effects of this mutation Reviewed by: on the overall metabolome and biosynthetic pathways in tea leaves. To gain further John A. Morgan, insight into the effects of chlorosis on the global metabolome and biosynthetic pathways Purdue University, USA Vinay Kumar, in this mutant, Huangjinya plants were grown under normal and reduced sunlight, Central University of Punjab, India resulting in chlorotic and non-chlorotic leaves, respectively; their leaves were analyzed *Correspondence: using transcriptomics as well as targeted and untargeted metabolomics. Approximately Jianyun Ruan 5,000 genes (8.5% of the total analyzed) and ca. 300 metabolites (14.5% of the total [email protected] detected) were significantly differentially regulated, thus indicating the occurrence of Specialty section: marked effects of light on the biosynthetic pathways in this mutant plant.
    [Show full text]
  • ATP-Citrate Lyase Has an Essential Role in Cytosolic Acetyl-Coa Production in Arabidopsis Beth Leann Fatland Iowa State University
    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2002 ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis Beth LeAnn Fatland Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Molecular Biology Commons, and the Plant Sciences Commons Recommended Citation Fatland, Beth LeAnn, "ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis " (2002). Retrospective Theses and Dissertations. 1218. https://lib.dr.iastate.edu/rtd/1218 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. ATP-citrate lyase has an essential role in cytosolic acetyl-CoA production in Arabidopsis by Beth LeAnn Fatland A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Plant Physiology Program of Study Committee: Eve Syrkin Wurtele (Major Professor) James Colbert Harry Homer Basil Nikolau Martin Spalding Iowa State University Ames, Iowa 2002 UMI Number: 3158393 INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleed-through, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted.
    [Show full text]
  • Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T
    Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T. Bourgeron,* D. Chretien,* J. Poggi-Bach, S. Doonan,' D. Rabier,* P. Letouze,I A. Munnich,* A. R6tig,* P. Landneu,* and P. Rustin* *Unite de Recherches sur les Handicaps Genetiques de l'Enfant, INSERM U393, Departement de Pediatrie et Departement de Biochimie, H6pital des Enfants-Malades, 149, rue de Sevres, 75743 Paris Cedex 15, France; tDepartement de Pediatrie, Service de Neurologie et Laboratoire de Biochimie, Hopital du Kremlin-Bicetre, France; IFaculty ofScience, University ofEast-London, UK; and IService de Pediatrie, Hopital de Dreux, France Abstract chondrial enzyme (7). Human tissue fumarase is almost We report an inborn error of the tricarboxylic acid cycle, fu- equally distributed between the mitochondria, where the en- marase deficiency, in two siblings born to first cousin parents. zyme catalyzes the reversible hydration of fumarate to malate They presented with progressive encephalopathy, dystonia, as a part ofthe tricarboxylic acid cycle, and the cytosol, where it leucopenia, and neutropenia. Elevation oflactate in the cerebro- is involved in the metabolism of the fumarate released by the spinal fluid and high fumarate excretion in the urine led us to urea cycle. The two isoenzymes have quite homologous struc- investigate the activities of the respiratory chain and of the tures. In rat liver, they differ only by the acetylation of the Krebs cycle, and to finally identify fumarase deficiency in these NH2-terminal amino acid of the cytosolic form (8). In all spe- two children. The deficiency was profound and present in all cies investigated so far, the two isoenzymes have been found to tissues investigated, affecting the cytosolic and the mitochon- be encoded by a single gene (9,10).
    [Show full text]
  • Pharmacological Inhibition of Tumor Anabolism and Host Catabolism As A
    www.nature.com/scientificreports OPEN Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy Alejandro Schcolnik‑Cabrera1,2, Alma Chavez‑Blanco1, Guadalupe Dominguez‑Gomez1, Mandy Juarez1, Ariana Vargas‑Castillo3, Rafael Isaac Ponce‑Toledo4, Donna Lai5, Sheng Hua5, Armando R. Tovar3, Nimbe Torres3, Delia Perez‑Montiel6, Jose Diaz‑Chavez1 & Alfonso Duenas‑Gonzalez1,7* The malignant energetic demands are satisfed through glycolysis, glutaminolysis and de novo synthesis of fatty acids, while the host curses with a state of catabolism and systemic infammation. The concurrent inhibition of both, tumor anabolism and host catabolism, and their efect upon tumor growth and whole animal metabolism, have not been evaluated. We aimed to evaluate in colon cancer cells a combination of six agents directed to block the tumor anabolism (orlistat + lonidamine + DON) and the host catabolism (growth hormone + insulin + indomethacin). Treatment reduced cellular viability, clonogenic capacity and cell cycle progression. These efects were associated with decreased glycolysis and oxidative phosphorylation, leading to a quiescent energetic phenotype, and with an aberrant transcriptomic landscape showing dysregulation in multiple metabolic pathways. The in vivo evaluation revealed a signifcant tumor volume inhibition, without damage to normal tissues. The six‑drug combination preserved lean tissue and decreased fat loss, while the energy expenditure got decreased. Finally, a reduction in gene expression associated with thermogenesis was observed. Our fndings demonstrate that the simultaneous use of this six‑drug combination has anticancer efects by inducing a quiescent energetic phenotype of cultured cancer cells. Besides, the treatment is well‑ tolerated in mice and reduces whole animal energetic expenditure and fat loss.
    [Show full text]
  • Robert Shine, Peter Dwyer, Lyndsay Olson, Jennifer Truong, Matthew Goddeeris, Effie Tozzo, Eric Bell Mitobridge, Inc
    Poster Title Here Mitochondrial Deficiency in Primary Muscle Cells from Mdx Mice Robert Shine, Peter Dwyer, Lyndsay Olson, Jennifer Truong, Matthew Goddeeris, Effie Tozzo, Eric Bell Mitobridge, Inc. Cambridge, MA 02138 Abstract Results Results Duchenne muscular dystrophy (DMD) is a recessive, fatal X-linked disease that is characterized M ito c h o n d ria l c o n trib u te d A T P is re d u c e d Mdx myoblasts have decreased expression by progressive skeletal muscle wasting due to a loss of function in dystrophin, a protein that is of OXPHOS complexes part of a complex that bridges the cytoskeleton and extracellular matrix. The mdx mouse, an in m d x m y o b la s ts a n d m y o tu b e s T animal model for DMD, has a point mutation in the dystrophin gene that results in a loss of 1 .5 2.0 W l function. This study uses primary muscle satellite cell derived myoblasts and myotubes to W T a WT m determine differences in mitochondrial biology between the mdx mice and wild type (WT) control s M D X o 1.5 a r MDX mice. Compared to cells isolated from WT mice, mdx cells have reductions in mitochondrial 1 .0 **** f B bioenergetics. Moreover, mdx cells have reduced levels of mitochondria which may partially *** e T g 1.0 explain the reduction in bioenergetics. Interestingly, the mitochondrial phenotype is apparent **** ** n * * W a * * * before dystrophin protein is increased during myogenesis. * * * 0 .5 h 0.5 * d l C o d l F 0.0 o 1 3 2 6 1 a 1 a b B 0 .0 F t v Materials and Analysis a 5 P X D C H H y 5 l l F X T N R O D a M in a M in D C s s P n n U A c c O S C C a 0 a 0 S y y T B 0 B 0 D WT and mdx myoblast isolation and culture: Quadricep and gastrocnemius muscles from a C 1 m 1 m Q A o o N single mouse were pooled and subjected to a mechanical/collagenase digestion.
    [Show full text]
  • Citric Acid Cycle
    CHEM464 / Medh, J.D. The Citric Acid Cycle Citric Acid Cycle: Central Role in Catabolism • Stage II of catabolism involves the conversion of carbohydrates, fats and aminoacids into acetylCoA • In aerobic organisms, citric acid cycle makes up the final stage of catabolism when acetyl CoA is completely oxidized to CO2. • Also called Krebs cycle or tricarboxylic acid (TCA) cycle. • It is a central integrative pathway that harvests chemical energy from biological fuel in the form of electrons in NADH and FADH2 (oxidation is loss of electrons). • NADH and FADH2 transfer electrons via the electron transport chain to final electron acceptor, O2, to form H2O. Entry of Pyruvate into the TCA cycle • Pyruvate is formed in the cytosol as a product of glycolysis • For entry into the TCA cycle, it has to be converted to Acetyl CoA. • Oxidation of pyruvate to acetyl CoA is catalyzed by the pyruvate dehydrogenase complex in the mitochondria • Mitochondria consist of inner and outer membranes and the matrix • Enzymes of the PDH complex and the TCA cycle (except succinate dehydrogenase) are in the matrix • Pyruvate translocase is an antiporter present in the inner mitochondrial membrane that allows entry of a molecule of pyruvate in exchange for a hydroxide ion. 1 CHEM464 / Medh, J.D. The Citric Acid Cycle The Pyruvate Dehydrogenase (PDH) complex • The PDH complex consists of 3 enzymes. They are: pyruvate dehydrogenase (E1), Dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3). • It has 5 cofactors: CoASH, NAD+, lipoamide, TPP and FAD. CoASH and NAD+ participate stoichiometrically in the reaction, the other 3 cofactors have catalytic functions.
    [Show full text]
  • Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: an Update
    International Journal of Molecular Sciences Review Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update Philippe Icard 1,2,3,*, Antoine Coquerel 1,4, Zherui Wu 5 , Joseph Gligorov 6, David Fuks 7, Ludovic Fournel 3,8, Hubert Lincet 9,10 and Luca Simula 11 1 Medical School, Université Caen Normandie, CHU de Caen, 14000 Caen, France; [email protected] 2 UNICAEN, INSERM U1086 Interdisciplinary Research Unit for Cancer Prevention and Treatment, Normandie Université, 14000 Caen, France 3 Service de Chirurgie Thoracique, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 4 INSERM U1075, COMETE Mobilités: Attention, Orientation, Chronobiologie, Université Caen, 14000 Caen, France 5 School of Medicine, Shenzhen University, Shenzhen 518000, China; [email protected] 6 Oncology Department, Tenon Hospital, Pierre et Marie Curie University, 75020 Paris, France; [email protected] 7 Service de Chirurgie Digestive et Hépato-Biliaire, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 8 Descartes Faculty of Medicine, University of Paris, Paris Center, 75006 Paris, France 9 INSERM U1052, CNRS UMR5286, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; [email protected] 10 ISPB, Faculté de Pharmacie, Université Lyon 1, 69373 Lyon, France 11 Department of Infection, Immunity and Inflammation, Institut Cochin, INSERM U1016, CNRS UMR8104, Citation: Icard, P.; Coquerel, A.; Wu, University of Paris, 75014 Paris, France; [email protected] Z.; Gligorov, J.; Fuks, D.; Fournel, L.; * Correspondence: [email protected] Lincet, H.; Simula, L.
    [Show full text]
  • Differential Regulation of Cysteine Oxidative Post-Translational
    www.nature.com/scientificreports OPEN Diferential regulation of cysteine oxidative post-translational modifcations in high and low Received: 16 April 2018 Accepted: 9 October 2018 aerobic capacity Published: xx xx xxxx Rodrigo W. A. Souza1, Christiano R. R. Alves 1,2, Alessandra Medeiros3, Natale Rolim4, Gustavo J. J. Silva4, José B. N. Moreira4, Marcia N. Alves4, Martin Wohlwend4, Mohammed Gebriel5, Lars Hagen5, Animesh Sharma 5, Lauren G. Koch6, Steven L. Britton7,8, Geir Slupphaug5, Ulrik Wisløf4,9 & Patricia C. Brum 1 Given the association between high aerobic capacity and the prevention of metabolic diseases, elucidating the mechanisms by which high aerobic capacity regulates whole-body metabolic homeostasis is a major research challenge. Oxidative post-translational modifcations (Ox-PTMs) of proteins can regulate cellular homeostasis in skeletal and cardiac muscles, but the relationship between Ox-PTMs and intrinsic components of oxidative energy metabolism is still unclear. Here, we evaluated the Ox-PTM profle in cardiac and skeletal muscles of rats bred for low (LCR) and high (HCR) intrinsic aerobic capacity. Redox proteomics screening revealed diferent cysteine (Cys) Ox-PTM profle between HCR and LCR rats. HCR showed a higher number of oxidized Cys residues in skeletal muscle compared to LCR, while the opposite was observed in the heart. Most proteins with diferentially oxidized Cys residues in the skeletal muscle are important regulators of oxidative metabolism. The most oxidized protein in the skeletal muscle of HCR rats was malate dehydrogenase (MDH1). HCR showed higher MDH1 activity compared to LCR in skeletal, but not cardiac muscle. These novel fndings indicate a clear association between Cys Ox-PTMs and aerobic capacity, leading to novel insights into the role of Ox- PTMs as an essential signal to maintain metabolic homeostasis.
    [Show full text]
  • PIM2-Mediated Phosphorylation of Hexokinase 2 Is Critical for Tumor Growth and Paclitaxel Resistance in Breast Cancer
    Oncogene (2018) 37:5997–6009 https://doi.org/10.1038/s41388-018-0386-x ARTICLE PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer 1 1 1 1 1 2 2 3 Tingting Yang ● Chune Ren ● Pengyun Qiao ● Xue Han ● Li Wang ● Shijun Lv ● Yonghong Sun ● Zhijun Liu ● 3 1 Yu Du ● Zhenhai Yu Received: 3 December 2017 / Revised: 30 May 2018 / Accepted: 31 May 2018 / Published online: 9 July 2018 © The Author(s) 2018. This article is published with open access Abstract Hexokinase-II (HK2) is a key enzyme involved in glycolysis, which is required for breast cancer progression. However, the underlying post-translational mechanisms of HK2 activity are poorly understood. Here, we showed that Proviral Insertion in Murine Lymphomas 2 (PIM2) directly bound to HK2 and phosphorylated HK2 on Thr473. Biochemical analyses demonstrated that phosphorylated HK2 Thr473 promoted its protein stability through the chaperone-mediated autophagy (CMA) pathway, and the levels of PIM2 and pThr473-HK2 proteins were positively correlated with each other in human breast cancer. Furthermore, phosphorylation of HK2 on Thr473 increased HK2 enzyme activity and glycolysis, and 1234567890();,: 1234567890();,: enhanced glucose starvation-induced autophagy. As a result, phosphorylated HK2 Thr473 promoted breast cancer cell growth in vitro and in vivo. Interestingly, PIM2 kinase inhibitor SMI-4a could abrogate the effects of phosphorylated HK2 Thr473 on paclitaxel resistance in vitro and in vivo. Taken together, our findings indicated that PIM2 was a novel regulator of HK2, and suggested a new strategy to treat breast cancer. Introduction ATP molecules.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Ketoconazole and Posaconazole Selectively Target HK2-Expressing Glioblastoma Cells
    Published OnlineFirst October 15, 2018; DOI: 10.1158/1078-0432.CCR-18-1854 Translational Cancer Mechanisms and Therapy Clinical Cancer Research Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells Sameer Agnihotri1, Sheila Mansouri2, Kelly Burrell2, Mira Li2, Mamatjan Yasin, MD2, Jeff Liu2,3, Romina Nejad2, Sushil Kumar2, Shahrzad Jalali2, Sanjay K. Singh2, Alenoush Vartanian2,4, Eric Xueyu Chen5, Shirin Karimi2, Olivia Singh2, Severa Bunda2, Alireza Mansouri7, Kenneth D. Aldape2,6, and Gelareh Zadeh2,7 Abstract Purpose: Hexokinase II (HK2) protein expression is eleva- in vivo. Treatment of mice bearing GBM with ketoconazole ted in glioblastoma (GBM), and we have shown that HK2 and posaconazole increased their survival, reduced tumor could serve as an effective therapeutic target for GBM. Here, we cell proliferation, and decreased tumor metabolism. In interrogated compounds that target HK2 effectively and addition, treatment with azoles resulted in increased pro- restrict tumor growth in cell lines, patient-derived glioma stem portion of apoptotic cells. cells (GSCs), and mouse models of GBM. Conclusions: Overall, we provide evidence that azoles exert Experimental Design: We performed a screen using a set of their effect by targeting genes and pathways regulated by HK2. 15 drugs that were predicted to inhibit the HK2-associated These findings shed light on the action of azoles in GBM. gene signature. We next determined the EC50 of the com- Combined with existing literature and preclinical results, these pounds by treating glioma cell lines and GSCs. Selected data support the value of repurposing azoles in GBM clinical compounds showing significant impact in vitro were used to trials.
    [Show full text]